MDxHealth SA (MDXH)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $13.75M
Last updated: Nov 17, 2026 at 11:03 AM ET
MDxHealth SA (MDXH) Stock Forecast
Analysts expect MDxHealth SA (MDXH) to earn -$0.46 per share in the fiscal year ending Dec 31, 2026, on revenue of $96.75M. Of 6 analysts, 1 rates the stock Buy or Strong Buy, 5 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 6 ratings average 2.83, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 17% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 1 | 16.7% |
| Hold | 5 | 83.3% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 6
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 12.2%.
- Fiscal year ending Dec 31, 2026
- -$0.46
- EPS consensus, revenue $96.75M
- Fiscal year ending Dec 31, 2027
- -$0.38
- EPS consensus, revenue $108.60M
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.46 | -$0.46 to -$0.46 | 1 | $96.75M | $87.08M to $100.69M | 6 |
| Dec 31, 2027 | -$0.38 | -$0.38 to -$0.38 | 1 | $108.60M | $90.52M to $115.46M | 6 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.09 | -$0.11 to -$0.07 | 7 | $26.38M | $22.05M to $32.66M | 7 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 2 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
EPS Trend
The EPS consensus for the fiscal year ending Dec 31, 2026 has held over the last 90 days.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.46 | -$0.46 | -$0.46 | -$0.46 | -$0.46 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.38 | -$0.38 | -$0.38 | -$0.38 | -$0.38 | N/A |
Frequently Asked Questions About MDXH
What is the MDXH stock forecast?
Consensus analyst estimates put MDxHealth SA's EPS at -$0.46 for the fiscal year ending Dec 31, 2026, on revenue of $96.75M. The consensus rating from 6 analysts is Hold.
How do analysts rate MDXH stock?
Of 6 analysts covering MDxHealth SA, 0 rate it Strong Buy, 1 Buy, 5 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from MDXH next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.46, with estimates from -$0.46 to -$0.46 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.38, with estimates from -$0.38 to -$0.38 from 1 analyst.
What revenue do analysts expect from MDxHealth SA next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $96.75M, with estimates from $87.08M to $100.69M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $108.60M, with estimates from $90.52M to $115.46M.
How many analysts cover MDXH?
6 analysts rate MDxHealth SA stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.
MDXH pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts